GENE

Genetic Technologies Ltd.
GENE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

GENE was delisted on the 16th of October, 2024.

Back to rankings

12 hedge funds and large institutions have $212K invested in Genetic Technologies Ltd. in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$9K
Puts
$1K
Net Calls
Net Calls Change

Top Buyers

1
+$60.2K
2
+$19K
3
+$12.3K
4
TSS
Two Sigma Securities
New York
+$11.9K
5
Citadel Advisors
Citadel Advisors
Florida
+$1.41K

Top Sellers

1
-$70K
2
-$56.4K
3
-$4.34K
4
NA
NewEdge Advisors
Louisiana
-$116
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$118K
2
$25.1K
3
$19K
4
$16.2K
5
$12.3K
6
$11.9K
7
$4.24K
8
$2.32K
9
$1.41K
10
$1.16K
11
–
12
–